$1.20
-0.52-30.23%
At Close: -
$1.24
0.043.33%
After Hours: 4:31 PM EDT
15 minutes delayed
Entero Therapeutics
ENTONASDAQ
Entero Therapeutics (ENTO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEntero Therapeutics (NASDAQ:ENTO) Stock Quotes, Forecast and News Summary
Entero Therapeutics Stock (NASDAQ: ENTO) stock price, news, charts, stock research, profile.
| Open | $1.54 |
| Close | $1.20 |
| Volume / Avg. | 1.23M / 27.63K |
| Day Range | 1.10 - 1.54 |
| 52 Wk Range | 1.70 - 3.16 |
| Market Cap | $3.52M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 17 |
| Short Interest | 0.32% |
| Days to Cover | 1 |
Recent News
No news found
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Entero Therapeutics (ENTO) stock?
You can purchase shares of Entero Therapeutics (NASDAQ:ENTO) through any online brokerage.
Who are Entero Therapeutics (ENTO) competitors?
Other companies in Entero Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Synaptogenix (NASDAQ:SNPX), Geovax Labs (NASDAQ:GOVX), NuCana (NASDAQ:NCNA) and Genprex (NASDAQ:GNPX).
What is the target price for Entero Therapeutics (ENTO) stock?
There is no analysis for Entero Therapeutics.
What is the forecast for Entero Therapeutics (ENTO) stock?
There is no analysis for Entero Therapeutics to provide a consensus price target.
Current stock price for Entero Therapeutics (ENTO)?
The stock price for Entero Therapeutics (NASDAQ: ENTO) is $1.24 last updated Today at June 27, 2024 at 4:31 PM EDT.
Does Entero Therapeutics (ENTO) pay a dividend?
There are no upcoming dividends for Entero Therapeutics.
When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?
Entero Therapeutics’s Q2 earnings are confirmed for Tuesday, August 20, 2024.
Is Entero Therapeutics (ENTO) going to split?
There is no upcoming split for Entero Therapeutics.
What sector and industry does Entero Therapeutics (ENTO) operate in?
Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.